70 results
424B7
EXAS
Exact Sciences Corp.
8 May 24
Prospectus with selling stockholder info
5:08pm
in our pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis.
Our Screening Tests
Cologuard Test
Colorectal … diagnostics, and are currently working to bring new, innovative cancer tests to patients throughout the world.
Our Screening Tests
Cologuard Test
8-K
EX-99.1
EXAS
Exact Sciences Corp.
8 May 24
Exact Sciences Announces First-Quarter 2024 Results
4:08pm
action earlier. Building on the success of the Cologuard and Oncotype DX tests, Exact Sciences is investing in its pipeline to develop innovative
8-K
EX-99.1
EXAS
Exact Sciences Corp.
17 Apr 24
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
4:01pm
and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis
8-K
EX-99.1
a857xsht0arjq
15 Apr 24
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
6:02am
8-K
EX-99.1
t74p8z net80
21 Feb 24
Exact Sciences Announces Fourth Quarter 2023 Results
4:40pm
8-K
EX-99.1
7f6d3180ksd4535q050
8 Jan 24
Exact Sciences Announces Preliminary Fourth Quarter 2023 Results
7:03am
8-K
EX-99
y3xkvxe9
1 Nov 23
Exact Sciences Announces Third-Quarter 2023 Results Reports record revenue, delivers more than a million test results, raises full-year guidance
4:09pm
8-K
EX-99
c5k68p6ty1 gi
1 Aug 23
Exact Sciences Announces Second-Quarter 2023 Results Reports record results, generates positive free cash flow, raises full-year guidance
4:08pm
S-3ASR
5v61s
25 May 23
Automatic shelf registration
4:01pm
8-K
EX-99
azlnvei
3 Nov 22
Exact Sciences Announces Third Quarter 2022 Results Reports Record Revenue, Raises Full-Year Guidance, Accelerates Path to Profitability
4:09pm